---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-23-046812"
form_type: "8-K"
ticker: "TLRY"
cik: "0001731348"
company_name: "Tilray Brands, Inc."
filed_at: "2023-10-04T23:59:59+00:00"
generated_at: "2026-06-10T04:53:13.874650+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Tilray acquires Ontario subsidiary from MediPharm for 1.37M shares; converts $50M note into 1.03M shares

## Summary
- Acquired all shares of 1000652011 Ontario Inc. from MediPharm Labs for 1,371,157 Tilray shares; earn-out up to 1,378,843 more if VWAP below $2.3958 by Oct 9, 2023.
- Issued 1,032,616 Tilray shares to HT Investments MA LLC upon conversion of $50M convertible note dated July 12, 2022.
- Both share issuances are unregistered: Regulation S for MediPharm, Section 3(a)(9) for HTI.

## SEC filing metadata
- accession: 0001140361-23-046812
- form_type: 8-K
- ticker: TLRY
- cik: 0001731348
- company_name: Tilray Brands, Inc.
- filed_at: 2023-10-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1731348/000114036123046812/0001140361-23-046812-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1731348/000114036123046812/ef20011830_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-23-046812
- JSON: https://secwatch.observer/filing/0001140361-23-046812.json
- Plain text: https://secwatch.observer/filing/0001140361-23-046812.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.